Enter your mobile number or email address below and we'll send you a link to download the free Kindle App. Then you can start reading Kindle books on your smartphone, tablet, or computer - no Kindle device required.

  • Apple
  • Android
  • Windows Phone
  • Android

To get the free app, enter your mobile phone number.

Buy Used
$6.94
+ $3.99 shipping
Used: Good | Details
Condition: Used: Good
Have one to sell? Sell on Amazon
Flip to back Flip to front
Listen Playing... Paused   You're listening to a sample of the Audible audio edition.
Learn more
See this image

Successful Biotech Investing: Every Investor's Complete Guide Hardcover – May 24, 2001

3.1 out of 5 stars 8 customer reviews

See all 3 formats and editions Hide other formats and editions
Price
New from Used from
Hardcover
"Please retry"
$11.00 $6.94

The Amazon Book Review
The Amazon Book Review
Author interviews, book reviews, editors picks, and more. Read it now
click to open popover

Editorial Reviews

Review

Because the Smart Investor is the Informed Investor

From the Back Cover

Because the Smart Investor is the Informed Investor
NO_CONTENT_IN_FEATURE

The latest book club pick from Oprah
"The Underground Railroad" by Colson Whitehead is a magnificent novel chronicling a young slave's adventures as she makes a desperate bid for freedom in the antebellum South. See more

Product Details

  • Hardcover: 416 pages
  • Publisher: Prima Lifestyles (May 2001)
  • Language: English
  • ISBN-10: 076153301X
  • ISBN-13: 978-0761533016
  • Product Dimensions: 9.3 x 6.3 x 1.3 inches
  • Shipping Weight: 1.4 pounds
  • Average Customer Review: 3.1 out of 5 stars  See all reviews (8 customer reviews)
  • Amazon Best Sellers Rank: #1,912,719 in Books (See Top 100 in Books)

Customer Reviews

Top Customer Reviews

By Jerome Beck on June 27, 2001
Format: Hardcover
This book is not just about biotech investing. Duarte, a technical analyst as well as a physician uses biotechs as a model for approaching the market. The book has all the shortcomings other reviewers warn you of: it's painfully redundant, incomplete and simplistic. But it does offer a consistent approach to stock investing IF you supplement it with other material. It also lists some neat web sites.
Comment 14 people found this helpful. Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback.
Sorry, we failed to record your vote. Please try again
Report abuse
Format: Hardcover
Dr. Duarte is an anesthesiologist, a professional stock commentator and an investment advisor. In this book he seeks to "bring stock picking and science together."
The book gives you a basic scientific background of the biotechnology industry, describes the way that the industry is regulated in creating new drugs, profiles the leading pharmaceutical and biotechnology companies, proposes a way to evaluate the fundamental performance of each company, and describes the ways that you can use technical analysis to pick when to buy and sell these stocks.
This helpful information is provided against the context of the wild swings in stock prices as the overall market and general news move stock price levels. He begins by pointing out that the statement by President Clinton and Prime Minister Blair that the rights of biotechnology companies should be restricted was a short-term storm, but a long-term non-event. Such moments provide buying opportunities.
The book has two basic weaknesses. First, it fails to point out that most people should avoid biotechnology stocks. They should be very volatile, and can have stomach-churning drops that will cause many investors to sell at the worst times. The vast majority of ordinary investors should be buying broad-based index funds (see Common Sense on Mutual Funds). Second, the book fails to point out that the rate of discoveries in any given company should be slowing down in the future. This is because after a company is public, it will usually limit R & D to try to create a profit track record and because the science is simply more difficult and lengthy as more proteins and enzymes become involved in solutions. As a result, we could see very long time periods when investments will be under water.
Read more ›
Comment 10 people found this helpful. Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback.
Sorry, we failed to record your vote. Please try again
Report abuse
Format: Hardcover
Don't waste your money, very basic and not very informative. Very generic!
Comment 9 people found this helpful. Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback.
Sorry, we failed to record your vote. Please try again
Report abuse
Format: Hardcover
This book provides the average investor with a solid foundation in their pursuit of successful biotech investing.

Most investors invest in biotech stocks based on media exposure and momentum driven markets. There is a glaring lack of any sort of structure to their research or position management. Dr. Duarte's book lays the groundwork for investors to establish a workable system of identifying and managing promising investments. By incorporating risk management techniques (technical analysis), he has provided a dose of reality to balance the inherent optimism the motivates biotech investors. This is crucial as it prevents the blow ups that destroy portfolios as well as investor confidence.
Comment 2 people found this helpful. Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback.
Sorry, we failed to record your vote. Please try again
Report abuse